Sagar Agarwal

Sagar Agarwal is a seasoned professional in clinical pharmacology with extensive experience in the biopharmaceutical industry. Currently serving as Vice President of Clinical Pharmacology at Kymera Therapeutics since April 2021, Sagar has previously held significant roles at Alnylam Pharmaceuticals as Global Clinical Pharmacology Lead for GIVLAARI™, and at Vertex Pharmaceuticals, where clinical pharmacology support was provided for drug development in HCV and cystic fibrosis. Prior experience includes positions at AbbVie, contributing to multiple neuroscience drug programs, and a research assistant role at the University of Minnesota, where Sagar earned a Ph.D. in Pharmaceutics. Sagar's educational background also includes a B.S. in Pharmaceutical Sciences from the University of Pune, India.